A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years

Research Site, Akashi-shi

Research Site, Chofu-shi

Research Site, Fuchu-shi

Research Site, Fujimi-shi

Research Site, Fukui-shi

Research Site, Fukuoka

Research Site, Fukuroi-shi

Research Site, Funabashi-shi

Research Site, Gifu

Research Site, Hatsukaichi-shi

Research Site, Hiroshima

Research Site, Ichikawa-shi

Research Site, Isumi

Research Site, Iwate-gun

Research Site, Katsushika-ku

Research Site, Kawasaki-shi

Research Site, Kisarazu-shi

Research Site, Kiyose-shi

Research Site, Kobe

Research Site, Koga-shi

Research Site, Kumamoto

Research Site, Kunitachi-shi

Research Site, Kuwana-shi

Research Site, Matsudo-shi

Research Site, Minatoku

Research Site, Morioka

Research Site, Nakano

Research Site, Okayama

Research Site, Ōta-ku

Research Site, Sapporo

Research Site, Sendai

Research Site, Setagaya-ku

Research Site, Shinjuku-ku

Research Site, Shizuoka

Research Site, Taito-ku

Research Site, Toshima-ku

Research Site, Tsu

Research Site, Yokkaichi-shi